A detailed history of Price T Rowe Associates Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 4,126,021 shares of ZTS stock, worth $730 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,126,021
Previous 4,793,925 13.93%
Holding current value
$730 Million
Previous $831 Million 3.0%
% of portfolio
0.09%
Previous 0.1%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$172.58 - $196.48 $115 Million - $131 Million
-667,904 Reduced 13.93%
4,126,021 $806 Million
Q2 2024

Aug 14, 2024

SELL
$145.54 - $178.83 $666 Million - $819 Million
-4,578,179 Reduced 48.85%
4,793,925 $831 Million
Q1 2024

May 15, 2024

SELL
$165.67 - $199.94 $720 Million - $869 Million
-4,344,577 Reduced 31.67%
9,372,104 $1.59 Billion
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $491 Million - $649 Million
3,244,074 Added 30.98%
13,716,681 $2.71 Billion
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $276 Million - $318 Million
1,651,255 Added 18.72%
10,472,607 $1.82 Billion
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $234 Million - $271 Million
-1,454,141 Reduced 14.15%
8,821,352 $1.52 Billion
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $321 Million - $386 Million
2,204,517 Added 27.31%
10,275,493 $1.71 Billion
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $306 Million - $368 Million
-2,335,030 Reduced 22.44%
8,070,976 $1.18 Billion
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $58.7 Million - $72.3 Million
395,882 Added 3.95%
10,406,006 $1.55 Billion
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $78.6 Million - $101 Million
504,073 Added 5.3%
10,010,124 $1.72 Billion
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $126 Million - $163 Million
696,998 Added 7.91%
9,506,051 $1.79 Billion
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $152 Million - $194 Million
-786,747 Reduced 8.2%
8,809,053 $2.15 Billion
Q3 2021

Nov 15, 2021

SELL
$189.29 - $209.69 $106 Million - $117 Million
-559,100 Reduced 5.51%
9,595,800 $1.86 Billion
Q2 2021

Aug 16, 2021

BUY
$155.9 - $187.99 $14.4 Million - $17.4 Million
92,590 Added 0.92%
10,154,900 $1.89 Billion
Q1 2021

May 17, 2021

BUY
$144.0 - $169.39 $131 Million - $155 Million
912,551 Added 9.97%
10,062,310 $1.58 Billion
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $1.44 Billion - $1.6 Billion
9,149,759 New
9,149,759 $1.51 Billion

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.